We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Chronic Snoring Remains After Surgery for Obese Children

By HospiMedica staff writers
Posted on 25 Mar 2008
Surgery to remove children's tonsils and adenoids to treat sleep-disordered breathing (SDB) may be successful in the short term, but children who gain weight rapidly tend to relapse or even worsen, according to a new study. More...


Researchers from the Cincinnati Children's Hospital Medical Center (OH, USA) used a sample of 40 healthy children, aged 7-13, who were treated for chronic snoring by adenotonsillectomy; a control group included 30 sex- and age-matched children who were not having the surgery. Each child underwent a polysomnography (PSG), a multi-parametric test used to study sleep, and apnea-hypopnea index (AHI) scores were measured. Before surgery, about 50% of the non-obese children and 67% of the obese children had an AHI score of greater than three. PSGs and AHIs were again performed at six weeks, six months, and a year after the surgery for both the treatment and control groups.

The researchers found that at six weeks after surgery, most of the children with SDB improved their scores. However, the rate of relapse after one year had no correlation with the six-week score. A year after surgery, 27% of the non-obese, and 79% of the obese children had AHI score of greater than three. The researchers concluded that these changes indicate that the surgery was significantly more effective in non-obese children after one year. Children who were obese at the baseline and, independently, children who had rapid BMI gain were more likely to relapse than those who lacked these characteristics; African-American origin was also associated with children who relapsed, as was high blood pressure. The study was published in the March 15, 2008, issue of the American Journal of Respiratory and Critical Care Medicine.

"These results highlight the differential disease mechanisms between those due to obesity and those due to the rapid change in body composition associated with accelerated BMI gain,” said lead author Raouf Amin, M.D. "The high rate of recurrence we observed in both obese and non-obese children indicates that SDB is a chronic condition.”


Related Links:
Cincinnati Children's Hospital Medical Center

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.